Cameroon vs Côte d'Ivoire: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cameroon
- Côte d'Ivoire
How they compare
Cameroon currently reports 29,674 deaths against 22,691 deaths in Côte d'Ivoire, a difference of 6,983 deaths.
That makes Cameroon's figure about 1.3 times Côte d'Ivoire's.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Côte d'Ivoire ahead.
Cameroon ranks 12th and Côte d'Ivoire ranks 14th of 157 countries.
Across the 4 decades both report, Cameroon averaged higher in 1 and Côte d'Ivoire in 2.
Head to head by decade
| Decade | Cameroon | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 4,683 deaths | 5,020 deaths | 336.88 deaths | Côte d'Ivoire |
| 2010s | 17,909 deaths | 19,082 deaths | 1,173 deaths | Côte d'Ivoire |
| 2020s | 28,409 deaths | 22,683 deaths | 5,726 deaths | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cameroon or Côte d'Ivoire?
- Cameroon, at 29,674 deaths against 22,691 deaths in Côte d'Ivoire as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cameroon and Côte d'Ivoire?
- 6,983 deaths, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Côte d'Ivoire?
- 35 years are reported by both, from 1990 to 2024.
- How do Cameroon and Côte d'Ivoire rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cameroon ranks 12th and Côte d'Ivoire ranks 14th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.